Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
About this item
Full title
Author / Creator
Publisher
United States: U.S. National Center for Infectious Diseases
Journal title
Language
English
Formats
Publication information
Publisher
United States: U.S. National Center for Infectious Diseases
Subjects
More information
Scope and Contents
Contents
We performed a follow-up of a previously reported SARS-CoV-2 prevalence study (April‒May 2020) in Verona, Italy. Through May 2022, only <1.1% of the city population had never been infected or vaccinated; 8.8% was the officially reported percentage. Limiting protection measures and vaccination boosters to elderly and frail persons seems justified.
Alternative Titles
Full title
Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2f5cbb2bb7444eb7bfebe71005402999
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2f5cbb2bb7444eb7bfebe71005402999
Other Identifiers
ISSN
1080-6040
E-ISSN
1080-6059
DOI
10.3201/eid2904.221268
